Back to 
Barclays plc
Barclays plc
IRD
8 quarters
Position history for Barclays plc's holdings in Opus Genetics, Inc.
Yes. Barclays holds 13,357 shares of IRD (Opus Genetics), worth $54,897, as of its Q2 2026 13F filing. It increased the position from 1,900 shares in Q1 2026. Barclays has held IRD since Q1 2025, across 6 quarterly 13F filings.
Current Value
$54,897
Current Shares
13,357
Total Value Change
+$52,408
Total Shares Change
+11,457
Quarter-by-Quarter History
Other major holders of IRD: Adage Capital Partners GP, L.L.C., BlackRock, Inc., Balyasny Asset Management L.P.